Advertisement

Clinical Evaluation of Abnormal Uterine Bleeding

  • Shalini Rajaram
  • Garima Yadav

Abstract

Abnormal uterine bleeding is one of the most common problems a woman faces in her reproductive life span, and it accounts for 20 % of visits to the gynecologic clinic. Abnormal uterine bleeding (AUB) is defined as “bleeding from the uterine corpus that is abnormal in regularity, volume, frequency or duration” and accounts for 25 % of all gynecologic procedures [1]. All clinicians dealing with a case of abnormal uterine bleeding face the basic challenge of excluding any genital tract malignancy by formulating a well-organized and logical approach for evaluation of the symptom. Abnormal uterine bleeding is caused by the disruption of normal physiology, anatomical changes in the endometrium, or endometrial malignancy; therefore, the role of detailed history and clinical examination of the pelvis, besides endometrial sampling and imaging studies, forms the backbone of evaluating this condition.

Keywords

Endometrial Cancer Endometrial Carcinoma Endometrial Thickness Endometrial Hyperplasia Endometrial Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Goldstein SR. Menorrhagia and abnormal uterine bleeding before the menopause. Best Pract Res Clin Obstet Gynaecol. 2004;18(1):59–69.CrossRefPubMedGoogle Scholar
  2. 2.
    Munroe MG, Critchley HO, Broder MS, Fraser IS. Causes of abnormal uterine bleeding in nongravid women of reproductive age. FIGO working group on menstrual disorders. Int J Gynaecol Obstet. 2011;113:3–13.CrossRefGoogle Scholar
  3. 3.
    Corbacioqlu Esmer A, Akbavir O, Goksedef BP, Gunduz N, Kisacik S, Daqdeviren H, et al. Is there an appropriate cut off age for sampling the endometrium in premenopausal bleeding? Gynecol Obstet Invest. 2014;77(1):40–4.CrossRefGoogle Scholar
  4. 4.
    ACOG Committee on Practice Bulletins – Gynecology, American College of Obstetricians and Gynecologists. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet. 2001;72(3):263–71.CrossRefGoogle Scholar
  5. 5.
    Ash SJ, Farrell SA, Flowerdew G. Endometrial biopsy in DUB. J Reprod Med. 1996;41(12):892–6.PubMedGoogle Scholar
  6. 6.
    Sorosky JI. Endometrial cancer. Obstet Gynecol. 2008;111(2 pt 1):436–47.CrossRefPubMedGoogle Scholar
  7. 7.
    Farquhar CM, Lethaby A, Sowter M, Verry J, Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol. 1999;181(3):525–9.CrossRefPubMedGoogle Scholar
  8. 8.
    44 NCG. Heavy menstrual bleeding. London: National Institute for Health and Clinical Excellence; 2007.Google Scholar
  9. 9.
    Critchley HO, Warner P, Lee AJ, Brechin S, Guise J, Graham B. Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Health Technol Assess. 2004;8(34):iii–iv, 1–139.CrossRefPubMedGoogle Scholar
  10. 10.
    Dijkhuizen FP, Mol BW, Brölmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000;89(8):1765–72.CrossRefPubMedGoogle Scholar
  11. 11.
    ACOG Committee opinion. Role of transvaginal scan in the evaluation of postmenopausal bleeding. Number 440, Aug 2009.Google Scholar
  12. 12.
    Fritz MA, Speroff L. Clinical gynaecologic endocrinology and infertility. 8th ed. Wolters Kluwer/LWW. 2010; p. 605.Google Scholar
  13. 13.
    de Vries LD, Dijkhuizen FP, Mol BW, Brölmann HA, Moret E, Heintz AP. Comparison of transvaginal sonography, saline infusion sonography, and hysteroscopy in premenopausal women with abnormal uterine bleeding. J Clin Ultrasound. 2000;28(5):217–23.CrossRefPubMedGoogle Scholar
  14. 14.
    Dueholm M, Forman A, Jensen ML, Laursen H, Kracht P. Transvaginal sonography combined with saline contrast sonohysterography in evaluating the uterine cavity in premenopausal patients with abnormal uterine bleeding. Ultrasound Obstet Gynecol. 2001;18(1):54–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy. Fertil Steril. 2001;76(2):350–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Davidson KG, Dubinsky TJ. Ultrasonographic evaluation of the endometrium in postmenopausal bleeding. Radiol Clin North Am. 2003;41(4):769–80.CrossRefPubMedGoogle Scholar
  17. 17.
    Vuento MH, Pirhonen JP, Makinen JI, Tyrkko JE, Laipalla PJ, Gronroos M, et al. Screening for endometrial cancer in asymptomatic postmenopausal women with conventional and colour Doppler sonography. BJOG. 1999;106:14–20.CrossRefGoogle Scholar
  18. 18.
    Mathew M, Gowri V, Rizvi SG. Saline infusion sonography-an effective tool for evaluation of endometrial cavity in women with abnormal uterine bleeding. Acta Obstet Gynecol Scand. 2010;89(1):140–2.CrossRefPubMedGoogle Scholar
  19. 19.
    Moschos E, Ashfaq R, McIntire DD, Liriano B, Twickler DM. Saline infusion sonography and endometrial sampling compared with endometrial biopsy in diagnosing endometrial pathology. Obstet Gynecol. 2009;113(4):881–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Abou-Salem N, Elmazny A, El-Sherbiny W. Value of 3-D sonohysterography for detection of intrauterine lesions in women with abnormal uterine bleeding. J Minim Invasive Gynecol. 2010;17(2):200–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. 2007;114(6):664–75.CrossRefPubMedGoogle Scholar
  22. 22.
    Lasmar RB, Barrozo PR, de Oliveira MA, Coutinho ES, Dias R. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding. J Minim Invasive Gynecol. 2006;13(5):409–12.CrossRefPubMedGoogle Scholar
  23. 23.
    Sismondi P, Biglia N, Volpi E, Giai M, de Grandis T. Tamoxifen and endometrial cancer. Ann N Y Acad Sci. 1994;734:310–21.CrossRefPubMedGoogle Scholar
  24. 24.
    Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P1 Study. J Natl Cancer Inst. 2005;97(22):1652–62.CrossRefPubMedGoogle Scholar
  25. 25.
    ACOG Committee opinion on tamoxifen and uterine cancer. Number 336, June 2006.Google Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyUniversity College of Medical Sciences and Guru Teg Bahadur HospitalDelhiIndia

Personalised recommendations